Clinical Trials Browser

Phase 2 × Lymphoma, Follicular × Thalidomide × Clear all

NCT00015912 2013-01-25

Interferon Alfa Plus Thalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Phase 2 Terminated

Lymphoma, Follicular

NCT00022581 2013-01-07

Thalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Phase 2 Completed

LymphoidOther hematologic neoplasm

Lymphoma, Follicular, Leukemia, Lymphocytic, Chronic, B-Cell